Filing summary
Identity warning: The request names Red Cat Holdings, Inc., but the filing identifies the registrant as Broadleaf Capital Partners, Inc. Verify that this is the intended filing. The report covers the quarter ended March 31, 2013, with operating results compared with the three months ended March 31, 2012.
Business context and financial results
Broadleaf describes itself as a diversified investment holding company seeking new investments after selling its Canyon Shadows Apartments interest in 2012. Pipeline Nutrition was its principal active operating business, selling nutritional products.
| Metric | Q1 2013 | Q1 2012 |
|---|---|---|
| Revenue | $10,377 | $633 |
| Cost of sales | $8,684 | $0 |
| Gross profit / margin | $1,693 / 16.3% | $633 / 100% |
| General and administrative expense | $29,783 | $62,354 |
| Net other income | $9,441 | $995,629 |
| Net income (loss) | ($18,649) | $933,908 in operations statement |
| Cash from operating activities | ($22,334) | $640,471 |
Q1 2013 revenue rose by $9,744, reflecting Pipeline Nutrition product sales. The company nevertheless reported a loss: gross profit did not cover operating expenses. The sharp year-over-year earnings decline primarily reflects the prior-year $947,427 investment-sale gain and $53,056 debt-forgiveness income, rather than comparable recurring operating performance. G&A fell by $32,571, principally because prior-year professional fees were higher.
Financial position and liquidity
At March 31, 2013, reported cash was $85,293, inventory $36,925, current assets $125,631, and total assets $125,631. Current liabilities and total liabilities were $95,611, including $30,383 of current notes payable, $17,066 of accrued interest, and $48,162 of accounts payable and accrued expenses. Long-term debt was reported as zero. Working capital was $30,020 and stockholders’ equity was $30,020; accumulated deficit was $14,278,585. Cash declined by $22,334 during the quarter. The filing says available cash was insufficient to fund operations for an extended period. No dividend is planned, and no numerical guidance is provided.
Outlook, risks, and other notable disclosures
- Going concern: Management says substantial doubt exists about the company’s ability to continue without additional capital and profitable operations. Plans include equity issuance, conversion of promissory notes to stock, and acquisitions; success is not assured.
- Debt and contingencies: Two notes were in default; creditors had not pursued collection. Accrued interest was $17,066. The filing reports no open or pending legal proceedings.
- Operating risks: Pipeline Nutrition had generated sales but not positive cash flow. Management cites limited capital, reliance on third parties, product-development and marketing uncertainty, and potential dilution from future financing.
- Controls: Management concluded disclosure controls and internal control over financial reporting were ineffective, citing limited experienced personnel, inadequate segregation of duties, and no audit committee or independent financial expert.
- Market and governance risks: The company describes its stock as a penny stock with limited trading liquidity and says it does not expect to pay dividends in the foreseeable future.
Important facts for investors to verify
- Confirm registrant identity: the supplied filing is for Broadleaf Capital Partners, Inc., not Red Cat Holdings, Inc.
- Resolve the balance-sheet comparative-date inconsistency: the balance-sheet heading shows March 31, 2012, while the index and notes refer to December 31, 2012.
- Reconcile cash-flow presentation: the 2012 cash-flow statement reports ending cash of $290,191, while the balance sheet reports $107,627 for its comparative cash balance.
- Check reported 2012 net income, shown as $933,908 in the operations statement and $933,909 in other parts of the filing.
- Assess the company’s ability to fund operations, address defaulted debt, and achieve positive cash flow from Pipeline Nutrition without substantial dilution.
- Review the disclosed material weaknesses and any subsequent remediation or changes in reporting controls.